Status:
COMPLETED
10-year Follow-up of Patients With Rheumatoid Arthritis Who Received Structured Treat-to-target Therapy in Early Disease
Lead Sponsor:
Diakonhjemmet Hospital
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The ARCTIC-FORWARD study is a multi-center prospective observational study investigating the long-term outcomes of rheumatoid arthritis (RA) patients who received structured treat-to-target therapy ea...
Detailed Description
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. Recent developments in RA treatment has shown to change the outcome of RA for the early stages of the disease, with very limite...
Eligibility Criteria
Inclusion
- All patients that entered the ARCTIC study are eligible for the follow-up study. The main inclusion criteria in the ARCTIC study were age 18-75 years, fulfilment of the 2010 ACR classification criteria for RA, DMARD naivety with indication from DMARD therapy, and symptom duration of less than two years.
Exclusion
- Psychiatric or mental disorders, alcohol abuse, other substance abuse, other factors making adherence to the study protocol impossible
Key Trial Info
Start Date :
December 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2024
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05304013
Start Date
December 22 2021
End Date
August 15 2024
Last Update
October 4 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Ålesund Hospital
Ålesund, Norway
2
Haukeland University Hospital
Bergen, Norway, 5021
3
Vestre Viken Hospital
Drammen, Norway
4
Haugesund Hospital, Helse Fonna
Haugesund, Norway